双极性障碍和单极性抑郁症患者的药物坚持态度:来自印度中部一个横截面研究的见解
Varchasvi Mudgal1, Priyash Jain2, Akanksha Singh1
1Department of Psychiatry, Mahatma Gandhi Memorial Medical College, Indore, Madhya Pradesh, India.
Journal of family medicine and primary care
|October 15, 2025
概括
高龄,男性性别和教育改善了抑郁症患者的药物坚持. 更多的发作与更好的坚持相关,突出了社会人口统计学因素对治疗成功的重要性.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物坚持对于单极性抑郁症和双极性障碍治疗结果至关重要.
- 即使在缓解期间,依从性挑战仍然存在,受临床和社会人口统计因素的影响.
- 了解这些影响是改善患者护理和坚持治疗的关键.
研究的目的:
- 为了评估单极抑郁症和双极障碍缓解期患者的药物坚持态度.
- 确定影响这些患者群体药物坚持的特定因素.
主要方法:
- 横截面研究设计. 截面研究设计.
- 包括诊断为单极抑郁症和双极障碍的患者在缓解期.
- 通过对社会人口统计和临床变量进行结构化访谈收集数据.
- 使用药物坚持库存规模测量药物坚持的测量.
- 统计分析以确定变量与依从之间的相关性.
主要成果:
- 年龄较大,男性性别和正规教育显著与更好的药物坚持有关.
- 更多的先前发作与改善的药物服药性有积极的相关性.
- 伴随性疾病和药物类型并没有对坚持态度产生重大影响.
结论:
- 社会人口统计学因素 (年龄,性别,教育) 显著影响抑郁症患者的药物坚持.
- 增加发作频率可能会促进更大的治疗承诺和坚持.
- 针对这些因素的干预措施可以提高患者的坚持和患者的结果,这需要进一步的个性化研究.
相关概念视频
Drug Therapy
242
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
242
Mania and Antimanic Drugs: Overview
549
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
549
Psychosis: Goals of Pharmacotherapy
469
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
469
Bipolar Disorder
619
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
619
Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823
Psychosis and Antipsychotic Drugs: Overview
816
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
816


